These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7679864

  • 1. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F, Peterson D, Hughes J, Milich DR.
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [Abstract] [Full Text] [Related]

  • 2. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
    Schödel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR.
    J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
    [Abstract] [Full Text] [Related]

  • 3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F, Peterson D, Hughes J, Wirtz R, Milich D.
    J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F, Peterson D, Milich D.
    Intervirology; 1996 Jan 26; 39(1-2):104-10. PubMed ID: 8957676
    [Abstract] [Full Text] [Related]

  • 5. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
    Schödel F, Kelly SM, Peterson D, Milich D, Hughes J, Tinge S, Wirtz R, Curtiss R.
    Dev Biol Stand; 1994 Jan 26; 82():151-8. PubMed ID: 7958469
    [Abstract] [Full Text] [Related]

  • 6. The hepatitis nucleocapsid as a vaccine carrier moiety.
    Milich DR, Peterson DL, Zheng J, Hughes JL, Wirtz R, Schödel F.
    Ann N Y Acad Sci; 1995 May 31; 754():187-201. PubMed ID: 7542855
    [Abstract] [Full Text] [Related]

  • 7. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F, Kelly S, Tinge S, Hopkins S, Peterson D, Milich D, Curtiss R.
    Adv Exp Med Biol; 1996 May 31; 397():15-21. PubMed ID: 8718577
    [Abstract] [Full Text] [Related]

  • 8. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.
    von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, Schödel F.
    Vaccine; 1993 May 31; 11(8):817-24. PubMed ID: 7689283
    [Abstract] [Full Text] [Related]

  • 9. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.
    Schödel F, Kelly SM, Peterson DL, Milich DR, Curtiss R.
    Infect Immun; 1994 May 31; 62(5):1669-76. PubMed ID: 8168928
    [Abstract] [Full Text] [Related]

  • 10. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
    Chen X, Li M, Le X, Ma W, Zhou B.
    Vaccine; 2004 Jan 02; 22(3-4):439-46. PubMed ID: 14670326
    [Abstract] [Full Text] [Related]

  • 11. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
    Tarar MR, Emery VC, Harrison TJ.
    FEMS Immunol Med Microbiol; 1996 Dec 31; 16(3-4):183-92. PubMed ID: 9116635
    [Abstract] [Full Text] [Related]

  • 12. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ, Chen M, Cheng T, He SZ, Li SW, Guan BQ, Zhu ZH, Gu Y, Zhang J, Xia NS.
    World J Gastroenterol; 2005 Jan 28; 11(4):492-7. PubMed ID: 15641132
    [Abstract] [Full Text] [Related]

  • 13. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S.
    Cell Immunol; 2007 May 28; 247(1):18-27. PubMed ID: 17707782
    [Abstract] [Full Text] [Related]

  • 14. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.
    Schödel F, Wirtz R, Peterson D, Hughes J, Warren R, Sadoff J, Milich D.
    J Exp Med; 1994 Sep 01; 180(3):1037-46. PubMed ID: 7520465
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S, Sroller V, Kunke D, Krystofová J, Kutinová L.
    Acta Virol; 1996 Sep 01; 40(5-6):273-9. PubMed ID: 9171455
    [Abstract] [Full Text] [Related]

  • 16. Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface.
    Borisova GP, Berzins I, Pushko PM, Pumpen P, Gren EJ, Tsibinogin VV, Loseva V, Ose V, Ulrich R, Siakkou H.
    FEBS Lett; 1989 Dec 18; 259(1):121-4. PubMed ID: 2480917
    [Abstract] [Full Text] [Related]

  • 17. Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen.
    Londoño LP, Chatfield S, Tindle RW, Herd K, Gao XM, Frazer I, Dougan G.
    Vaccine; 1996 Apr 18; 14(6):545-52. PubMed ID: 8782354
    [Abstract] [Full Text] [Related]

  • 18. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R, Werr M, Birkner M, Hilfrich R, Streeck RE.
    J Gen Virol; 1995 Sep 18; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
    Ulrich R, Borisova GP, Gren E, Berzin I, Pumpen P, Eckert R, Ose V, Siakkou H, Gren EJ, von Baehr R.
    Arch Virol; 1992 Sep 18; 126(1-4):321-8. PubMed ID: 1381912
    [Abstract] [Full Text] [Related]

  • 20. Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.
    Sominskaya I, Skrastina D, Dislers A, Vasiljev D, Mihailova M, Ose V, Dreilina D, Pumpens P.
    Clin Vaccine Immunol; 2010 Jun 18; 17(6):1027-33. PubMed ID: 20410327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.